Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
16.56
0.00 (-0.03%)
May 5, 2026, 2:45 PM EDT - Market open

Takeda Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
52,80946,80043,60151,23745,31657,094
Market Cap Growth
13.24%7.34%-14.90%13.07%-20.63%20.72%
Enterprise Value
83,23170,55870,04977,51972,14749,779
Last Close Price
16.5614.8713.8916.4814.3218.26
PE Ratio
73.3266.3246.1521.6723.9116.93
PS Ratio
1.851.531.551.691.551.98
PB Ratio
1.081.010.911.070.972.30
P/TBV Ratio
0.010.010.010.010.010.02
P/FCF Ratio
8.258.1912.208.135.527.03
P/OCF Ratio
6.966.649.226.964.916.26
EV/Sales Ratio
2.922.312.492.562.461.72
EV/EBITDA Ratio
10.249.5811.268.918.415.16
EV/EBIT Ratio
21.6330.8849.5420.9819.0610.83
EV/FCF Ratio
13.0012.3519.6112.308.796.13
Debt / Equity Ratio
0.560.570.620.640.730
Debt / EBITDA Ratio
4.434.095.143.804.16-
Debt / FCF Ratio
4.805.278.965.244.35-
Net Debt / Equity Ratio
0.540.590.600.600.61-0.29
Net Debt / EBITDA Ratio
3.743.724.643.323.32-0.76
Net Debt / FCF Ratio
4.054.808.084.583.47-0.90
Asset Turnover
0.290.310.290.300.300.27
Inventory Turnover
1.171.301.301.352.352.34
Quick Ratio
0.580.450.510.500.750.54
Current Ratio
1.191.011.110.971.210.65
Return on Equity (ROE)
1.50%1.52%2.12%5.27%4.55%8.21%
Return on Assets (ROA)
1.26%1.44%4.02%3.06%2.92%4.42%
Return on Invested Capital (ROIC)
1.35%1.54%4.36%3.38%3.21%4.78%
Return on Capital Employed (ROCE)
2.69%2.79%1.76%4.36%4.60%5.18%
Earnings Yield
1.36%1.51%2.17%4.61%4.18%5.91%
FCF Yield
12.13%12.21%8.19%12.30%18.12%14.23%
Dividend Yield
3.19%4.30%4.36%4.11%5.20%4.48%
Payout Ratio
117.40%280.28%199.34%88.14%123.30%75.36%
Buyback Yield / Dilution
-0.25%-1.58%-0.67%0.46%-0.23%-0.47%
Total Shareholder Return
2.94%2.72%3.70%4.58%4.97%4.02%
Updated Jan 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q